$QGEN News

Qiagen Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak; Says Qiagen’s FDA-Cleared QIAstat-Dx Gastrointestinal Panel 2 Can Detect Cyclospora Infections In About An Hour As Part Of A 16-Target Gastrointestinal Pathogens Menu

Qiagen: New Launches Signal A Turnaround

Morgan Stanley Upgrades Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis - Slideshow

Qiagen N.V. (QGEN) Shareholder/Analyst Call - Slideshow

Qiagen N.V. (QGEN) Shareholder/Analyst Call Transcript

Morgan Stanley Upgrades Qiagen to Overweight, Raises Price Target to $42

Qiagen N.V. (QGEN) Presents at JP Morgan European Healthcare Conference 2026 - Slideshow

Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis Transcript

QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma

QIAGEN Expands QIAcuity Digital PCR Portfolio Into Gene Expression, Cell And Gene Therapy And Automated Workflows To Drive Broader Adoption Across Life Sciences

Qiagen (QGEN) Up 12.1% Since Last Earnings Report: Can It Continue?

Qiagen N.V. (QGEN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Qiagen N.V. (QGEN) Presents at Deutsche Bank German Corporate Conference - Slideshow

Evaluating Qiagen (QGEN) Valuation After Recent Short Term Share Price Recovery

QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak

QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows

QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA

Stifel Maintains Hold on Qiagen, Lowers Price Target to $36

Qiagen N.V. (QGEN) Price Target Decreased by 13.91% to 46.28